Role of the cyclin-dependent kinase 4 and 6 inhibitor gene family p15, p16, p18 and p19 in leukemia and lymphoma

Leukemia and Lymphoma

Volumn 23, Issue 5-6, 1996, Pages 505-520

  Siebert, Reiner ^a   Willers, Christoph P ^a   Opalka, Bertram ^a,b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

Author keywords

CDK inhibitors; Cyclin dependent kinases (CDK); Leukemia lymphoma

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE;

CANCER CELL CULTURE; CANCER GENETICS; CELL CYCLE; ENZYME INHIBITION; GENE MAPPING; HUMAN; LEUKEMIA; LYMPHOMA; MULTIGENE FAMILY; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0030463184     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609054859     Document Type: Review

References (107)

1. Cordon-Cardo, C. (1995) Mutation of cell cycle regulators. Am. J. Pathol., 147, 545-560.
2. Roberts, J. M., Koff, A., Polyak, K., Firpo, R., Collins, S., Ohtsubo, M. and Massague, J (1994) Cyclins, CDKs, and cyclin kinase inhibitors. Cold Spring Harbour Symposia on Quantitative Biology, 59, 31-38.
3. Biggs, J. R. and Kraft, A. S. (1995) Inhibitors of cyclin-dependent kinase and cancer. J. Mol. Med., 73, 509-514.
4. Nurse, P. (1994) Ordering S phase and M phase in the cell cycle. Cell, 79, 547-550.
5. Grana, X. and Reddy, E P. (1995) Cell cycle control in mammalian cells, role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene, 11, 211-219.
6. Xiong, Y., Zhang, H. and Beach, D. (1992) D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell, 71, 505-514.
7. Dulic, V., Lees, E. and Reed, S. I. (1992) Association of human cyclin E with a periodic G1-S-phase protein kinase. Science, 257, 1958-1961.
8. Ohtsubo, M. and Roberts, J. M (1993) Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science, 259, 1908-1912.
9. Resnitzky, D., Gossen, M., Bujard, H. and Reed, S. I. (1994) Acceleration of G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol., 14, 1669-1679.
10. Weinberg, R. A. (1995) The retinoblastoma protein and cell cycle control. Cell., 81, 323-330.
11. Rosenblatt, J., Gu, Y. and Morgan, D. O. (1992) Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A. Proc. Natl. Acad. Sci. USA, 89, 2824-2828.
12. Lewin, B. (1990) Driving the cell cycle: M phase kinase, its partners, and substrates. Cell, 61, 743-752
13. cdc2-cyclin B complex by the human WEE1 tyrosine kinase. Science, 257, 1955-1957.
14. cdc2 on tyrosine 15. J. Biol. Chem., 269, 30530-30537.
15. Hartwell, L. H. and Kastan, M. B. (1994) Cell cycle control and cancer. Science, 266, 1821-1828.
16. Hirama, T. and Koeffler, H. P. (1995) Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood, 86, 841-854.
17. Hatakeyama, M., Herrera, R. A., Makela, T., Dowdy, S. F., Jacks, T. and Weinberg, R. A. (1994) The cancer cell and the cell cycle clock. Cold Spring Harbour symposia on quantitative biology, 59, 1-10.
18. Motokura, T. and Arnold, A. (1993) Cyclins and oncogenesis. Bioch. Bioph. Acta, 1155, 63-78.
19. Delmer, A., Ajchenbaum-Cymbalista, F., Tang, R., Ramond, S., Faussat, A., Marie, J. and Zittoun, R. (1995) Over-expression of cyclin D1 in chronic B-cell malignancies with abnormality of chromosome 11q13. Br. J. Haem., 89, 798-804.
20. Serrano, M., Hannon, G. J. and Beach, D. (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclinD/CDK4. Nature, 366, 704-707.
21. Kamb, A., Gruis, N A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day III, R. S , Johnson B E and Skolnick, M. H. (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440.
22. Guidal-Giroux, C., Gerard, B., Cave, H., Duval, M., Rohrlich, P., Elion, J., Vilmer, E. and Grandchamp, B. (1996) Deletion mapping indicates that MTS1 is the target of frequent deletions at chromosome 9p21 in paediatric acute lymphoblastic lekaemias. Br. J. Haem , 92, 410-419.
23. Xiong, Y., Zhang, H and Beach, D. (1993) Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev , 7, 1572-1583.
24. INK4A tumor suppressor protein. Cancer Res., 55, 2503-2506.
25. INK4. Cancer Res., 54, 5816-5820.
26. Yeager, T., Stadler, W., Belair, C., Puthenveettil, J., Olopade, O. and Reznikoff, C. (1995) Increase of p16 levels correlate with pRB alterations in human urothelial cells. Cancer Res., 55, 493-497.
27. Shapiro, G. I., Edwards, C. D., Kobzik, L., Godleski, J., Richards, W., Sugarbaker, D. J. and Rollins, B. J. (1995) Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Cancer Res., 55, 505-509.
28. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature, 371, 257-261.
29. INK4B/MTS2 -related CDK6 inhibitor correlates with wild-type pRB function. Genes Dev., 8, 2939-2952
30. INK4. Mol. Cell. Biol., 15, 2682-2688.
31. Nobori, T , Miura, K., Wu, D. J., Lois, A., Takabayashi, K. and Carson, D. A. (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature, 368, 753-756.
32. ink4 and retinoblastoma tumour-suppressor genes occur in distinct sub-sets of human cancer cell lines. Int J. Cancer, 61, 115-120.
33. INK4B in Non-Hodgkin's Lymphomas. Blood, 86, 1534-1539.
34. Liu, Q., Neuhausen, S., McClure, M., Frye, C., Weaver-Feldhaus, J., Gruis, N. A., Eddington, K., Allalunis-Turner, M. J., Skolnick, M. H., Fujimura, F. K. and Kamb, A. (1995) CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines. Oncogene, 10, 1061-1067.
35. Nakamaki, T., Kawamata, N., Schwaller, J., Tobler, A., Fey, M., Pakkala, S., Lee, Y. Y., Kim, B. K., Fukuchi, K., Tsuruoka, N., Kahan, J., Miller, C. W. and Koeffler, H. P. (1995) Structural integrity of the cyclin-dependent kinase inhibitor genes, p15, p16 and p18 in myeloid leukaemias. Br. J. Haem., 91, 139-149.
36. Ogawa, S., Hirano, N., Sato, N., Takahashi, T., Hangaishi, A., Tanaka, K., Kurokawa, M., Tanaka, T., Mitani, K., Yazaki, Y. and Hirai, H (1994) Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias. Blood, 84, 2431-2435
37. INK4 in human cancer. Proc. Natl. Acad. Sci. USA, 91, 11045-11049.
38. Ohnishi, H., Kawamura, M., Ida, K., Sheng, X. M., Hanada, R., Nobori, T., Yamamori, S. and Hayashi, Y. (1995) Homozygous deletions of p16/MTS1 gene are frequent but mutations are infrequent in childhood T-cell acute lymphoblastic leukemia. Blood, 86, 1269-1275.
39. INK4B/MTS2 in human leukemias and lymphomas. Cancer Res., 55, 1436-1440.
40. Stranks, G., Height, S. E., Mitchell, P., Jadayel, D., Yuille, M A. R., DeLord, C., Clutterbuck, R. D , Treleaven, J. G., Powles, R L., Nacheva, E , Oscier, D G., Karpas, A , Lenoir, G. M., Smith, S. D , Millar, J. L., Catovsky, D. and Dyer, M. J. S. (1995) Deletions and rearrangements of CDKN2 in lymphoid malignancy. Blood, 85, 893-901.
41. ink4) gene in cell lines established from children with acute lymphoblastic leukemia. Leukemia, 9, 1159-1161.
42. Siebert, R., Willers, C. P., Schramm, A., Fosså, A., Gana Dresen, I. M., Uppenkamp, M., Nowrousian, M. R., Seeber, S. and Opalka, B. (1995) Homozygous loss of the MTS1/p16 and MTS2/p15 genes in lymphoma and lymphoblastic leukaemia cell lines. Br. J. Haem., 91, 350-354.
43. Siebert, R., Willers, C. P., Fosså, A., Kloke, O., Nowrousian, M. R., Seeber, S. and Opalka, B. (1996) Analysis of the novel cyclin-dependent kinase 4 and 6 inhibitor gene p18 in lymphoma and leukemia cell lines. Leuk. Res., 20, 197-200
44. Schröder, M., Mathieu, U., Dreyling, M., Bohlander, S. K., Hagemeijer, A., Beverloo, B. H., Olopade, O. I., Stilgenbauer, S., Fischer, K., Bentz, M., Lichter, P. and Döhner, H. (1995) CDKN2 gene deletion is not found in chronic lymphoid leukaemias of B-and T-cell origin but is frequent in acute lymphoblastic leukaemia. Br. J. Haem., 91, 865-870.
45. Diaz, M. O., Ziemin, S., Le Beau, M. M., Pitha, P., Smith, S. D., Chilcote, R. R. and Rowley, J. D. (1988) Homozygous deletion of the alpha- and beta-1-interferon genes in human leukemia and derived cell lines. Proc. Natl. Acad. Sci. USA, 85, 5259-5263.
46. Diaz, M. O., Rubin, C. M., Harden, A., Ziemin, S., Larson R. A., Le Beau, M. M. and Rowley, J. D. (1990) Deletions of interferon genes in acute lymphoblastic leukemia N. Engl. J. Med., 322, 77-82.
47. Raimondi, S. C. (1993) Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood, 81, 2237-2251.
48. Heim, S. and Mitelman, F. (1992) Cytogenetic analysis in the diagnosis of acute leukemia. Cancer, 70, 1701-1709.
49. Rabbits, T. H. (1994) Chromosomal translocations in human cancer. Nature, 372, 143-149.
50. Iolascon, A , Faienza, M. F., Coppola, B., Ragione, F. D., Santoro, N. and Schettini, F. (1995) High frequency of homozygous deletions of CDK4I gene in childhood acute lymphoblastic leukaemia. Br. J. Haem., 91, 647-651.
51. INK4A) deletion in primary tumor cells of 163 leukemic patients. Blood, 85, 854.
52. INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias. Blood, 84, 4038-4044
53. INK4A/MTS1) gene structure and expression in acute lymphoblastic leukemias. Leukemia, 9, 1240-1245.
54. Duro, D., Flexor, M , Bernard, O., d'Agay, M., Berger, R. and Larsen, C. (1994) Alterations of the putative tumor suppressor gene p16/MTS1 in human hematologic malignancies. C. R. Acad. Sci. Paris III, 317, 913-919.
55. Fizzotti, M., Cimino, G., Pisegna, S., Alimena, G., Quartarone, C., Mandelli, F., Pelicci, P. G. and Lo Coco, F. (1995) Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic factors. Blood, 85, 2685-2690.
56. Ogawa, S., Hangaishi, A., Miyawaki, S., Hirosawa, Miura, Y., Takeyama, K., Kamada, N , Ohtake, S., Uike, N., Shimazaki, C., Toyama, K., Hirano, M., Mizoguchi, H., Kobayashi, Y., Furusawa, S., Saito, M., Emi, N., Yazaki, Y., Ueda, R. and Hirai, H. (1995) Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies. Blood, 86, 1548-1556.
57. Quesnel, B., Preudhomme, C., Philippe, N., Vanrumbeke, M., Dervite, I., Lai, J L., Bauters, F., Wattel, E. and Fenaux, P. (1995) p16 gene homozygous deletions in acute lymphoblastic leukemia. Blood, 85, 657-663.
58. ink4 gene inactivation in acute lymphocytic leukemia. Blood, 85, 3431-3436.
59. Stock, W., Sher, D. A., Dodge, R. K., Westbrook, C. A., Larson, R. A., Arthur, D., Frankel, S. R., Soble, R. E., Davey, F. R., Schneider, D., Diaz, M. and Bloomfield, C. D. (1995) High incidence of p16 deletion in adult acute lymphoblastic leukemia (ALL): correlation with clinical features and response to treatment. Blood, 86 (Suppl. 1), 268a.
60. Takeuchi, S., Bartram, C. R., Seriu, T., Miller, C. W., Tobler, A., Janssen, J. W. G., Reiter, A., Ludwig, W. D., Zimmermann, M., Schwaller, J., Lee, E., Miyoshi, I. and Koeffler, H. P. (1995) Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Blood, 86, 755-760.
61. INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood, 85, 2321-2330.
62. INK4 gene in childhood acute lymphoblastic leukemia even when blasts display loss of heterozygosity in the 9p21 chromosomic region. Blood, 84 (Suppl. 1), 297a.
63. Yang, C. H. and Perentesis, J. P. (1995) Novel CDKN2 (p16-INK4A) mutations in hematologic malignancies: potential insight into the structural basis of cell cycle regulation. Blood, 86 (Suppl. 1), 748a.
64. INK4A gene deletions in childhood acute Iymphoblastic leukemias. Leuk. Res., 19, 883-885.
65. Sill, H., Goldman, J. M. and Cross, N. C. P. (1995) Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia. Blood, 85, 2013-2016.
66. Iolascon, A., Faienza, M. F., Coppola, B., Ragione, F. D., Schettini, F. and Biondi, A. (1995) CDKI genes in T-cell ALL. Blood, 86 (Suppl. 1), 328a.
67. Yu, A. L., Diccianni, M. B., Batova, A., Vu, T., Pullen, J., Amylon, M., Pollock, B. and Yu, J. (1995) High frequency alterations of the p16 and p15, but not p18, CDK inhibitors in T cell acute lymphoblastic leukemia. Blood, 86 (Suppl. 1), 268a.
68. Berger, R. (1991) Chromosomal abnormalities in T-cell malignant lymphoma. Bull. Cancer, 78, 283-290.
69. Kamada, N , Sakurai, M., Miyamoto, K., Sanada, I., Sadamori, N., Fukuhara, S , Abe, S., Shiraishi, Y., Abe, T., Kaneko, Y. and Shimoyama, M. (1992) Chromosome abnormalities in adult T-cell leukemia/lymphoma: a karyotype review committee report Cancer Res., 52, 1481-1493.
70. Fujiwara, H., Arima, N., Hidaka, S., Ohtsubo, H., Matsushita, K , Kukita, T., Arimura, K., Tanaka, H and Shima, T. (1995) Alteration of the CDKN2 (p16/INK4A/MTS1) gene in adult T-cell leukemia/lymphoma (ATLL). Blood, 86 (Suppl. 1), 563a.
71. Hatta, Y., Hirama, T., Miller, C. W., Yamada, Y., Tomonaga, M. and Koeffler, H. P. (1995) Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. Blood, 85, 2699-2704.
72. Hatta, Y., Morosetti, R., Hirama, T., Kawamata, N., Yamada, Y., Tomonaga, M., Miller, C. W. and Koeffler, H. P. (1995) Mutational analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, p18, p19 and p27/Kip1 genes and the Rb gene in adult T-cell leukemia. Blood, 86 (Suppl. 1), 563a.
73. Huret, J. L., Brizard, A., Babin, P., Schoenwald, M., Briault, S., Guilhot, F. and Tanzer, J. (1990) Translocation (8;9)(q12;p21): a new non-random rearrangement in lymphoid malignancies. Cancer Genet Cytogenet., 45, 125-129.
74. Offit, K., Parsa, N. Z., Jhanwar, S. C., Filippa, D., Wachtel, M. and Chaganti, R. S. K. (1993) Clusters of chromosome 9 aberrations are associated with clinico-pathologic subsets of non-Hodgkin's lymphoma. Genes Chrom. Cancer, 7, 1-7.
75. Chaganti, S. R., Gaidano, G., Louie, D. C., Dalla-Favera, R. and Chaganti, R. S. K. (1995) Diffuse large cell lymphomas exhibit frequent deletions in 9p21-22 and 9q31-34 regions. Genes Chrom. Cancer, 12, 32-36.
76. Offit, K. (1992) Chromosome analysis in the management of patients with Non-Hodgkin's lymphoma. Leuk. Lymph., 7, 275-282.
77. Offit, K., Wong, G., Filippa, D. A., Tao, Y. and Chaganti, R. S. K. (1991) Cytogenetic analysis of 434 consecutively ascertained specimens of Non-Hodgkin's Lymphoma: Clinical Correlations. Blood, 77, 1508-1515.
78. The Non-Hodgkin's Lymphoma Pathologic Classification Project (1982) National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage. Cancer, 49, 2112-2135.
79. Dreyling, M. H., Bohlander, S. K., Vardiman, J. R. and Olopade, O. I. (1995) CDKN2 deletion is a frequent event in the histologic transformation to diffuse large cell lymphoma. Blood, 86 (Suppl. 1), 329a.
80. INK4 (9p21), and DBM (13q14)) in B-cell chronic lymphocytic leukemia. Mol. Carcinogenesis, 14, 141-146.
81. Koduru, P. R. K., Zariwala, M., Soni, M., Gong, J Z., Xiong, Y. and Broome, J. D. (1995) Deletion of the cyclin-dependent kinase 4 inhibitor genes p15 and p16 in Non-Hodgkin's Lymphoma. Blood, 86, 2900-2905.
82. ink4A) gene in primary B-cell lymphomas. Blood, 86, 2724-2731.
83. Williams, M. E., Woytowitz, D., Finkelstein, S. D. and Swerdlow, S. H. (1995) MTS1/MTS2 (p15/p16) deletions and p53 mutations in mantle cell (centrocytic) lymphoma. Blood, 86 (Suppl. 1), 747a.
84. Schröder, M., Mathieu, U., Dreyling, M. H., Bohlander, S. K., Hagemeijer, A., Olopade, O. I., Stilgenbauer, S., Möller, P., Fischer, K., Bentz, M., Lichter, P. and Döhner, H. (1995) Detection of CDKN2 gene deletions in lymphoid malignancies by fluorescence in situ hybridization (FISH). Med. Genetik, 2, 41.
85. Shiohara, M., Gombart, A. F., Morosetti, R., Said, J. W., Spirin, K and Koeffler, H. P (1995) Mutational analysis of CDKIs in a large series of Non-Hodgkin's lymphomas. Blood, 86 (Suppl. 1), 823a.
86. Schlegelberger, B., Weber-Matthiesen, K., Himmler, A., Bartels, H., Sonnen, R., Kuse, R., Feller, A. C. and Grote, W. (1994) Cytogenetic findings and results of combined immunophenotyping and karyotyping in Hodgkin's disease. Leukemia, 8, 72-80.
87. + Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease. Blood, 86, 1464-1468.
88. Sawyer, J. R., Waldron, J. A., Jagannath, S. and Barlogie, B. (1995) Cytogenetic findings in 200 patients with multiple myeloma. Cancer Genet Cytogenet., 82, 41-49.
89. Tasaka, T., Berenson, J., Hirama, T. and Koeffler, H. P. (1995) Analysis of the INK4 family of genes in multiple myeloma. Blood, 86 (Suppl. 1), 63a.
90. Bloomfield, C. D. and de la Chapelle, A. (1987) Chromosome abnormalities in acute nonlymphocytic leukemia: clinical and biological significance. Sem. Oncol., 14, 372-383.
91. Hirsch-Ginsberg, C., Huh, Y. O., Kagan, J., Liang, J. C. and Stass, S. A. (1993) Advances in the diagnosis of acute leukemia. Haem. Oncol. Clinics North America, 7, 1-46.
92. Bennett, J. M., Catovsky, D., Daniel, M., Flandrin, G., Galton, D. A. G., Gralinck, H R. and Sultan, C. (1976) Proposals for the classification of the acute leukemias Br. J. Haem., 33, 451-458.
93. Heim, S. (1992) Cytogenetic findings in primary and secondary MDS. Leuk. Res., 16, 43-46.
94. Mitelman, F. (1993) The cytogenetic scenario of chronic myeloid leukemia. Leuk. Lymph., 11 (Suppl. 1), 11-15.
95. Serra, A., Gottardi, E., Ragione, F. D., Saglio, G. and Iolascon, A. (1995) Involvement of the cyclin-dependent kinase-4 inhibitor (CDKN2) gene in the pathogenesis of lymphoid blast crisis of chronic myelogenous leukaemia. Br. J. Haem., 91, 625-629.
96. Garicochea, B., Bendit, I., Giorgi, R., Manzella, L., Dorlhiac-Llacer, P. E., Chamone, D. A. F. and Bydlowski, S. P. (1995) NF1, p15 and p16 tumor suppressor genes in chronic myelogenous leukemia in chronic phase and blast crisis. A mutational analysis Blood, 86 (Suppl. 1), 794a.
97. Hodgson, S. V. and Maher, E. R. (1993) A practical guide to human cancer genetics. Cambridge, UK: Cambridge University Press.
98. INK4 gene inactivation in childhood acute lymphocytic leukemia. Blood, 86 (Suppl. 1), 175a.
99. Pollock, P. M. Pearson, J. V. and Hayward, N. K. (1996) Compilation of somatic mutations of the CDKN2 gene in human cancers: Non-random distribution of base substitutions. Genes Chrom. Cancer., 15, 77-88.
100. Gonzalez-Zulueta, M., Bender, C. M., Yang, A. S., Nguyen, T., Beart, R. W., Tomout, M. V. and Jones, P. A. (1995) Methylation of the 5′CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissue correlates with gene silencing Cancer Res., 55, 4531-4535.
101. Herman, J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J. J., Davidson, N. E., Sidransky, D. and Baylin, S. B. (1995) Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55, 4525-4530.
102. INK4/MTS1 gene transcript expressed in B-cell malignancies. Oncogene, 11, 21-29.
103. INK4A transcript. Cancer Res., 55, 2995-2997.
104. Lois, A. F., Cooper, L. T., Geng, Y., Nobori, T. and Carson, D. (1995) Expression of the p16 and p15 cyclin-dependent kinase inhibitors in lymphocyte activation and neuronal differentiation. Cancer Res., 55, 4010-4013.
105. Gombart, A. F., Campbell, M. J., Yang, R., Cho, S. K., Tun, R. Y. M. and Koeffler, H. P. (1995) Retroviral transfer and expression of the human p16INK4A gene inhibits the proliferation of human leukemias. Blood, 86 (Suppl. 1), 432a.
106. Quesnel, B., Preudhomme, C., Lepelley, P. Hetuin, D., Vanrumbeke, M., Bauters, F., Velu, T. and Fenaux, P. (1995) Transfer of p16 gene in leukemic cell lines with p16 homozygous deletion inhibits cell proliferation. Blood, 86 (Suppl. 1), 432a.
107. Zhang, X , Jin, X., Consoli, U., Zhao, S., Jiang, S., Roth, J. and Andreeff, M. (1995) Adenovirus delivered p16/CDKN2 gene decreases cell proliferation and induces erythroid differentiation in K562 cells. Blood, 86 (Suppl. 1), 148a